Fecarotta S, Tarallo A, Damiano C, Minopoli N, Parenti G (2020) Pathogenesis of mucopolysaccharidoses, an update. Int J Mol Sci 21(7):2515. https://doi.org/10.3390/ijms21072515

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiśniewska K, Wolski J, Gaffke L, Cyske Z, Pierzynowska K, Węgrzyn G (2022) Misdiagnosis in mucopolysaccharidoses. J Appl Genet 63(3):475–495. https://doi.org/10.1007/s13353-022-00703-1

Article  PubMed  Google Scholar 

Muschol N, Giugliani R, Jones SA et al (2022) Sanfilippo syndrome: consensus guidelines for clinical care. Orphanet J Rare Dis 17(1):391. https://doi.org/10.1186/s13023-022-02484-6

Article  PubMed  PubMed Central  Google Scholar 

Faraguna MC, Musto F, Crescitelli V et al (2022) Mucopolysaccharidosis-plus syndrome, a rapidly progressive disease: favorable impact of a very prolonged steroid treatment on the clinical course in a child. Genes 13(3):442. https://doi.org/10.3390/genes13030442

Article  CAS  PubMed  PubMed Central  Google Scholar 

Żuber Z, Kieć-Wilk B, Kałużny Ł, Wierzba J, Tylki-Szymańska A (2023) Diagnosis and management of mucopolysaccharidosis type II (hunter syndrome) in Poland. Biomedicines 11(6):1668. https://doi.org/10.3390/biomedicines11061668

Article  CAS  PubMed  PubMed Central  Google Scholar 

D’Avanzo F, Rigon L, Zanetti A, Tomanin R (2020) Mucopolysaccharidosis type II: one hundred years of research, diagnosis, and treatment. Int J Mol Sci 21(4):1258. https://doi.org/10.3390/ijms21041258

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hampe CS, Yund BD, Orchard PJ, Lund TC, Wesley J, McIvor RS (2021) Differences in MPS I and MPS II disease manifestations. Int J Mol Sci 22(15):7888. https://doi.org/10.3390/ijms22157888

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barone R, Pellico A, Pittalà A, Gasperini S (2018) Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses. Ital J Pediatr 44(Suppl 2):121. https://doi.org/10.1186/s13052-018-0561-2

Article  PubMed  PubMed Central  Google Scholar 

Węgrzyn G, Jakóbkiewicz-Banecka J, Narajczyk M et al (2010) Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different? Med Hypotheses 75(6):605–609. https://doi.org/10.1016/j.mehy.2010.07.044

Article  CAS  Google Scholar 

Conijn T, Nijmeijer SCM, van Oers HA, Wijburg FA, Haverman L (2019) Psychosocial functioning in parents of MPS III patients. In: Morava E, Baumgartner M, Patterson M, Rahman S, Zschocke J, Peters V (eds) JIMD reports, vol 44. Springer. Berlin, Heidelberg, pp 33–41

Google Scholar 

Grant N (2021) Evaluating strategies to manage and endure challenging behaviors in mucopolysaccharidoses. Orphanet J Rare Dis 16(1):165. https://doi.org/10.1186/s13023-021-01767-8

Article  PubMed  PubMed Central  Google Scholar 

Hoffmann F, Hoffmann S, Kunzmann K, Ries M (2020) Challenging behavior in mucopolysaccharidoses types I-III and day-to-day coping strategies: a cross sectional explorative study. Orphanet J Rare Dis 15:275. https://doi.org/10.1186/s13023-020-01548-9

Article  PubMed  PubMed Central  Google Scholar 

Porter KA, O’Neill C, Drake E et al (2020) Parent experiences of sanfilippo syndrome impact and unmet treatment needs: a qualitative assessment. Neurol Ther 10(1):197–212. https://doi.org/10.1007/s40120-020-00226-z

Article  PubMed  PubMed Central  Google Scholar 

Porter KA, O’Neill C, Drake E et al (2022) Caregivers’ assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome. J Patient-Report Outcomes 6(1):40. https://doi.org/10.1186/s41687-022-00447-w

Article  Google Scholar 

Shapiro EG, Jones SA, Escolar ML (2017) Developmental and behavioral aspects of mucopolysaccharidoses with brain manifestations—Neurological signs and symptoms. Mol Genet Metab 122S:1–7. https://doi.org/10.1016/j.ymgme.2017.08.009

Article  CAS  PubMed  Google Scholar 

Somanadhan S, Bristow H, Crushell E et al (2021) IMPACT study: measuring the impact of caregiving on families and healthcare professionals of children and adults living with mucopolysaccharidoses in Ireland. Ther Adv Rare Dis 2:26330040211020764. https://doi.org/10.1177/26330040211020764

Article  PubMed  PubMed Central  Google Scholar 

Hassall S, Smith DM, Rust S, Wittkowski A (2022) A systematic review and integrative sequential explanatory narrative synthesis: the psychosocial impact of parenting a child with a lysosomal storage disorder. J Inherit Metab Dis 45(3):406–416. https://doi.org/10.1002/jimd.12482

Article  PubMed  PubMed Central  Google Scholar 

Zhou J, Lin J, Leung WT, Wang L (2020) A basic understanding of mucopolysaccharidosis: incidence, clinical features, diagnosis, and management. Intractable Rare Dis Res 9(1):1–9. https://doi.org/10.5582/irdr.2020.01011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Porter KA, O’Neill C, Drake E et al (2022) Caregivers’ assessment of meaningful and relevant clinical outcome assessments for Sanfilippo syndrome. J Patient Rep Outcomes 6:40. https://doi.org/10.1186/s41687-022-00447-w

Article  PubMed  PubMed Central  Google Scholar 

Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A (2013) Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatr 102(5):462–470. https://doi.org/10.1111/apa.12169

Article  PubMed  PubMed Central  Google Scholar 

Zelei T, Csetneki K, Vokó Z, Siffel C (2018) Epidemiology of Sanfilippo syndrome: results of a systematic literature review. Orphanet J Rare Dis 13(1):53. https://doi.org/10.1186/s13023-018-0796-4

Article  PubMed  PubMed Central  Google Scholar 

Wiśniewska K, Gaffke L, Krzelowska K, Węgrzyn G, Pierzynowska K (2022) Differences in gene expression patterns, revealed by RNA-seq analysis, between various Sanfilippo and Morquio disease subtypes. Gene 812:146090. https://doi.org/10.1016/j.gene.2021.146090

Article  CAS  PubMed  Google Scholar 

Pierzynowska K, Gaffke L, Podlacha M, Węgrzyn G (2020) Genetic base of behavioral disorders in mucopolysaccharidoses: transcriptomic studies. Int J Mol Sci 21(3):1156. https://doi.org/10.3390/ijms21031156

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saghi M, InanlooRahatloo K, Alavi A, Kahrizi K, Najmabadi H (2022) Intellectual disability associated with craniofacial dysmorphism due to POLR3B mutation and defect in spliceosomal machinery. BMC Med Genom 15:89. https://doi.org/10.1186/s12920-022-01237-5

Article  CAS  Google Scholar 

Brands MMG, Güngör D, van den Hout JMP et al (2015) Pain: a prevalent feature in patients with mucopolysaccharidosis. Results of a cross-sectional national survey. J Inherit Metab Dis 38(2):323–331. https://doi.org/10.1007/s10545-014-9737-0

Article  CAS  PubMed  Google Scholar 

Gnasso R, Corrado B, Iommazzo I et al (2022) Assessment, pharmacological therapy and rehabilitation management of musculoskeletal pain in children with mucopolysaccharidoses: a scoping review. Orphanet J Rare Dis 17(1):255. https://doi.org/10.1186/s13023-022-02402-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas S, Ramaswami U, Cleary M, Yaqub M, Raebel EM (2021) Gastrointestinal manifestations in mucopolysaccharidosis type III: review of death certificates and the literature. J Clin Med 10(19):4445. https://doi.org/10.3390/jcm10194445

Article  PubMed  PubMed Central  Google Scholar 

Congedi S, Orzalesi M, Di Pede C, Benini F (2018) Pain in mucopolysaccharidoses: analysis of the problem and possible treatments. Int J Mol Sci 19(10):3063. https://doi.org/10.3390/ijms19103063

Article